A range of malignancies, including melanoma, glioblastoma, and pancreatic, colorectal, and hepatocellular carcinomas, are characterized by a reduced expression of ASS1, resulting in a dependence on extracellular L-arg [75]. Here, ASS1 is linked to hepatocellular carcinoma.